Endovascular treatment of a patient with Takayasu arteritis


Takayasu arteritis, stenosis, stent

How to Cite

Tasheva, I., Petrov, I., Pavlova, S., Grozdinski, L., & Stankov, Z. (2020). Endovascular treatment of a patient with Takayasu arteritis. Rheumatology (Bulgaria), 27(4), 42-48. https://doi.org/10.35465/27.4.2019.pp42-48


Takayasu arteritis is a chronic, rare arteritis that causes arterial stenosis / occlusion and dilation, affects the aorta and its branches. The most commonly affected branches are the subclavian artery and the common carotid artery. It is mainly diagnosed in women under 40 years of age. It is most commonly observed in Japan, Southeast Asia, India and Mexico.  We represent a clinical case of a patient with Takayasu arteritis, with diagnosed significant stenosis of the common carotid arteries and subclavian artery. Doppler sonography was used for screening. Endovascular treatment of lesions with different localization has been applied in stages. They have been successfully and effectively treated by implanting different types of stent on the Takayasu-affected artery lesions. No intra-procedural major events were observed, as well as death or severe complications during the follow-up.

Keywords: Takayasu arteritis, stenosis, stent



  1. Numano F, Kobayashi Y. Takaysau arteritis – beyond pulselessness. Intern Med. 1999;38:226-32.
  2. Numano F, Kobayashi Y. Takayasu arteritis: beyond pulselessness. Intern Med. 1999;38:226-232.
  3. Hotchi M. Pathological studies on Takayasu arteritis. Heart and Vessels. 1992;7:11-17.
  4. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathology. 2002;55:481-486.
  5. Moriwaki R, Noda M, Yajima M et al. Clinical manifestation of Takayasu arteritis in India and Japan-new classification of angiographic findings. Angiology 1997;48:369-379.
  6. Kerr GS, Hallahan CW, Giordano J. Takayasu arteritis. Annals of Intern Med, 1994;120:919-929.
  7. Ishikawa K. Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu arteriopathy. J Am Coll Cardiol. 1988;12:964-972.
  8. Arend WP, Michel BA, Bloch DA. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129-34.
  9. Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis: a preliminary report from the International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol. 1998;66:S191-S194.
  10. Maksimowicz-McKinnon K, Clark TM, Hoff man GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis and Rheum 2007;56:1000-1009.
  11. Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu’s disease:clinical and statistical analyses of related prognostic factors. Circulation 1994;90:1855-1860.
  12. Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int. J Cardiol. 1996;54:S155-63.
  13. Karageorgaki ZT, Bertsias GK, Mavragani CP et al. Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece. Clin Exp Rheumatol. 2009;27:S33-9.
  14. Bicakcigil M, Aksu K, Kamali S. Takayasu‘s arteritis in Turkey – clinical and angiographic features of 248 patients. Clin Exp Rheumatol. 2009;27:S59-64.
  15. Miyata T, Sato O, Koyama H et al. Long-term survival after surgical treatment of patients with Takayasu’s arteritis. Circulation. 2003;108:1474-80.
  16. Perera A, Youngstein T, Gibbs R et al. Optimizing the outcome of vascular intervention for Takayasu arteritis. British Journal of Surgery. 2014;101:43-50.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.